Quote | Coeptis Therapeutics Inc (OTCMKTS:COEP)
Last: | $8.13 |
---|---|
Change Percent: | 142.69% |
Open: | $9 |
Close: | $3.35 |
High: | $12.13 |
Low: | $7 |
Volume: | 112,009 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Coeptis Therapeutics Inc (OTCMKTS:COEP)
Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering PR Newswire Bolsters Company's Corporate Mission Financing Led by Board Member and Priced at Premium to Market Price WEXFORD, Pa. , June 20, 2024 /PRNewswire/ --...
Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting PR Newswire WEXFORD, Pa. , May 30, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutica...
Message Board Posts | Coeptis Therapeutics Inc (OTCMKTS:COEP)
Subject | By | Source | When |
---|---|---|---|
... going concern ...? | 4570govt | investorshub | 04/25/2023 12:09:57 PM |
Back in $1.44 average looking real good for | tw0122 | investorshub | 04/19/2023 8:01:20 PM |
NEWS: Coeptis Therapeutics Signs Agreement to Acquire Allogeneic | jedijazz | investorshub | 04/18/2023 12:04:09 PM |
Today looking for $1.61 but other then that | tw0122 | investorshub | 04/18/2023 11:09:42 AM |
Yeah definitely not going to happen... lol | ghosttrader13 | investorshub | 04/17/2023 12:49:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Coeptis Therapeutics Inc Company Name:
COEP Stock Symbol:
OTCMKTS Market:
Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering PR Newswire Bolsters Company's Corporate Mission Financing Led by Board Member and Priced at Premium to Market Price WEXFORD, Pa. , June 20, 2024 /PRNewswire/ --...
Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting PR Newswire WEXFORD, Pa. , May 30, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutica...
Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024 PR Newswire WEXFORD, Pa. , May 8, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company ...